FDA FY2020 Drug Inspection Observations and Trends
By Barbara W. Unger
Identify new FDA inspection trends to proactively address similar situations in your company.
Topics of this report include:
- Data from FY2020 FDA drug GMP inspections
- Trends from five years of GMP inspections
- Conclusions drawn from an analysis of drug inspection data
